Exploring the Anti-Osteoporotic Potential of Daucosterol: Impact on Osteoclast and Osteoblast Activities

Osteoporosis is a debilitating condition characterized by reduced bone mass and density, leading to compromised structural integrity of the bones. While conventional treatments, such as bisphosphonates and selective estrogen receptor modulators (SERMs), have been employed to mitigate bone loss, thei...

Full description

Bibliographic Details
Main Authors: Sumin Lee, Jae-Hyun Kim, Minsun Kim, Sooyeon Hong, Hoyeon Park, Eom Ji Kim, Eun-Young Kim, Chungho Lee, Youngjoo Sohn, Hyuk Sang Jung
Format: Article
Language:English
Published: MDPI AG 2023-11-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/24/22/16465
_version_ 1797458986240311296
author Sumin Lee
Jae-Hyun Kim
Minsun Kim
Sooyeon Hong
Hoyeon Park
Eom Ji Kim
Eun-Young Kim
Chungho Lee
Youngjoo Sohn
Hyuk Sang Jung
author_facet Sumin Lee
Jae-Hyun Kim
Minsun Kim
Sooyeon Hong
Hoyeon Park
Eom Ji Kim
Eun-Young Kim
Chungho Lee
Youngjoo Sohn
Hyuk Sang Jung
author_sort Sumin Lee
collection DOAJ
description Osteoporosis is a debilitating condition characterized by reduced bone mass and density, leading to compromised structural integrity of the bones. While conventional treatments, such as bisphosphonates and selective estrogen receptor modulators (SERMs), have been employed to mitigate bone loss, their effectiveness is often compromised by a spectrum of adverse side effects, ranging from gastrointestinal discomfort and musculoskeletal pain to more severe concerns like atypical fractures and hormonal imbalances. Daucosterol (DC), a natural compound derived from various plant sources, has recently garnered considerable attention in the field of pharmacology. In this study, we investigated the anti-osteoporosis potential of DC by characterizing its role in osteoclasts, osteoblasts, and lipopolysaccharide (LPS)-induced osteoporosis. The inhibitory effect of DC on osteoclast differentiation was determined by tartrate-resistant acid phosphatase (TRAP) staining, F-actin ring formation by fluorescent staining, and bone resorption by pit formation assay. In addition, the calcification nodule deposition effect of osteoblasts was determined by Alizarin red S staining. The effective mechanisms of both cells were verified by Western blot and reverse transcription polymerase chain reaction (RT-PCR). To confirm the effect of DC in vivo, DC was administered to a model of osteoporosis by intraperitoneal administration of LPS. The anti-osteoporosis effect was then characterized by micro-CT and serum analysis. The results showed that DC effectively inhibited osteoclast differentiation at an early stage, promoted osteoblast activity, and inhibited LPS-induced bone density loss. The results of this study suggest that DC can treat osteoporosis through osteoclast and osteoblast regulation, and therefore may be considered as a new therapeutic alternative for osteoporosis patients in the future.
first_indexed 2024-03-09T16:45:01Z
format Article
id doaj.art-70759402753e43cabe06afef6d23c81b
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-09T16:45:01Z
publishDate 2023-11-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-70759402753e43cabe06afef6d23c81b2023-11-24T14:47:45ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672023-11-0124221646510.3390/ijms242216465Exploring the Anti-Osteoporotic Potential of Daucosterol: Impact on Osteoclast and Osteoblast ActivitiesSumin Lee0Jae-Hyun Kim1Minsun Kim2Sooyeon Hong3Hoyeon Park4Eom Ji Kim5Eun-Young Kim6Chungho Lee7Youngjoo Sohn8Hyuk Sang Jung9Department of Anatomy, College of Korean Medicine, Kyung Hee University, 26, Kyunghee dae-ro, Dongdaemun-gu, Seoul 02-447, Republic of KoreaDepartment of Anatomy, College of Korean Medicine, Kyung Hee University, 26, Kyunghee dae-ro, Dongdaemun-gu, Seoul 02-447, Republic of KoreaDepartment of Anatomy, College of Korean Medicine, Kyung Hee University, 26, Kyunghee dae-ro, Dongdaemun-gu, Seoul 02-447, Republic of KoreaDepartment of Anatomy, College of Korean Medicine, Kyung Hee University, 26, Kyunghee dae-ro, Dongdaemun-gu, Seoul 02-447, Republic of KoreaDepartment of Anatomy, College of Korean Medicine, Kyung Hee University, 26, Kyunghee dae-ro, Dongdaemun-gu, Seoul 02-447, Republic of KoreaDepartment of Anatomy, College of Korean Medicine, Kyung Hee University, 26, Kyunghee dae-ro, Dongdaemun-gu, Seoul 02-447, Republic of KoreaDepartment of Anatomy, College of Korean Medicine, Kyung Hee University, 26, Kyunghee dae-ro, Dongdaemun-gu, Seoul 02-447, Republic of KoreaDepartment of Anatomy, College of Korean Medicine, Kyung Hee University, 26, Kyunghee dae-ro, Dongdaemun-gu, Seoul 02-447, Republic of KoreaDepartment of Anatomy, College of Korean Medicine, Kyung Hee University, 26, Kyunghee dae-ro, Dongdaemun-gu, Seoul 02-447, Republic of KoreaDepartment of Anatomy, College of Korean Medicine, Kyung Hee University, 26, Kyunghee dae-ro, Dongdaemun-gu, Seoul 02-447, Republic of KoreaOsteoporosis is a debilitating condition characterized by reduced bone mass and density, leading to compromised structural integrity of the bones. While conventional treatments, such as bisphosphonates and selective estrogen receptor modulators (SERMs), have been employed to mitigate bone loss, their effectiveness is often compromised by a spectrum of adverse side effects, ranging from gastrointestinal discomfort and musculoskeletal pain to more severe concerns like atypical fractures and hormonal imbalances. Daucosterol (DC), a natural compound derived from various plant sources, has recently garnered considerable attention in the field of pharmacology. In this study, we investigated the anti-osteoporosis potential of DC by characterizing its role in osteoclasts, osteoblasts, and lipopolysaccharide (LPS)-induced osteoporosis. The inhibitory effect of DC on osteoclast differentiation was determined by tartrate-resistant acid phosphatase (TRAP) staining, F-actin ring formation by fluorescent staining, and bone resorption by pit formation assay. In addition, the calcification nodule deposition effect of osteoblasts was determined by Alizarin red S staining. The effective mechanisms of both cells were verified by Western blot and reverse transcription polymerase chain reaction (RT-PCR). To confirm the effect of DC in vivo, DC was administered to a model of osteoporosis by intraperitoneal administration of LPS. The anti-osteoporosis effect was then characterized by micro-CT and serum analysis. The results showed that DC effectively inhibited osteoclast differentiation at an early stage, promoted osteoblast activity, and inhibited LPS-induced bone density loss. The results of this study suggest that DC can treat osteoporosis through osteoclast and osteoblast regulation, and therefore may be considered as a new therapeutic alternative for osteoporosis patients in the future.https://www.mdpi.com/1422-0067/24/22/16465daucosterolbone metabolismosteoporosisosteoclastosteoblast
spellingShingle Sumin Lee
Jae-Hyun Kim
Minsun Kim
Sooyeon Hong
Hoyeon Park
Eom Ji Kim
Eun-Young Kim
Chungho Lee
Youngjoo Sohn
Hyuk Sang Jung
Exploring the Anti-Osteoporotic Potential of Daucosterol: Impact on Osteoclast and Osteoblast Activities
International Journal of Molecular Sciences
daucosterol
bone metabolism
osteoporosis
osteoclast
osteoblast
title Exploring the Anti-Osteoporotic Potential of Daucosterol: Impact on Osteoclast and Osteoblast Activities
title_full Exploring the Anti-Osteoporotic Potential of Daucosterol: Impact on Osteoclast and Osteoblast Activities
title_fullStr Exploring the Anti-Osteoporotic Potential of Daucosterol: Impact on Osteoclast and Osteoblast Activities
title_full_unstemmed Exploring the Anti-Osteoporotic Potential of Daucosterol: Impact on Osteoclast and Osteoblast Activities
title_short Exploring the Anti-Osteoporotic Potential of Daucosterol: Impact on Osteoclast and Osteoblast Activities
title_sort exploring the anti osteoporotic potential of daucosterol impact on osteoclast and osteoblast activities
topic daucosterol
bone metabolism
osteoporosis
osteoclast
osteoblast
url https://www.mdpi.com/1422-0067/24/22/16465
work_keys_str_mv AT suminlee exploringtheantiosteoporoticpotentialofdaucosterolimpactonosteoclastandosteoblastactivities
AT jaehyunkim exploringtheantiosteoporoticpotentialofdaucosterolimpactonosteoclastandosteoblastactivities
AT minsunkim exploringtheantiosteoporoticpotentialofdaucosterolimpactonosteoclastandosteoblastactivities
AT sooyeonhong exploringtheantiosteoporoticpotentialofdaucosterolimpactonosteoclastandosteoblastactivities
AT hoyeonpark exploringtheantiosteoporoticpotentialofdaucosterolimpactonosteoclastandosteoblastactivities
AT eomjikim exploringtheantiosteoporoticpotentialofdaucosterolimpactonosteoclastandosteoblastactivities
AT eunyoungkim exploringtheantiosteoporoticpotentialofdaucosterolimpactonosteoclastandosteoblastactivities
AT chungholee exploringtheantiosteoporoticpotentialofdaucosterolimpactonosteoclastandosteoblastactivities
AT youngjoosohn exploringtheantiosteoporoticpotentialofdaucosterolimpactonosteoclastandosteoblastactivities
AT hyuksangjung exploringtheantiosteoporoticpotentialofdaucosterolimpactonosteoclastandosteoblastactivities